The Role of Carbamoyl Phosphate Synthetase 1 as a Prognostic Biomarker in Patients With Acetaminophen-induced Acute Liver Failure

Raymond Kwan,Lu Chen,Min-Jung Park,Zemin Su,M Bishr Omary,Sujith V.W. Weerasinghe,William M. Lee,Valerie L. Durkalski-Mauldin,Robert J. Fontana
DOI: https://doi.org/10.1016/j.cgh.2023.03.002
IF: 13.576
2023-04-12
Clinical Gastroenterology and Hepatology
Abstract:Background & Aims Carbamoyl phosphate synthetase 1 (CPS1) is a highly abundant mitochondrial urea cycle enzyme that is expressed primarily in hepatocytes. CPS1 is constitutively and physiologically secreted into bile but is released into the bloodstream upon acute liver injury (ALI). Given its abundance and known short half-life, we tested the hypothesis that it may serve as a prognostic serum biomarker in the setting of acute liver failure (ALF). Methods CPS1 levels were determined using enzyme-linked immunosorbent assay and immunoblotting of sera collected by the ALF Study Group (ALFSG) from patients with ALI and ALF (103 patients with acetaminophen and 167 non-acetaminophen ALF etiologies). A total of 764 serum samples were examined. The inclusion of CPS1 was compared with the original ALFSG Prognostic Index by area under the receiver operating characteristic curve analysis. Results CPS1 values for acetaminophen-related patients were significantly higher than for non-acetaminophen patients ( P < .0001). Acetaminophen-related patients who received a liver transplant or died within 21 days of hospitalization exhibited higher CPS1 levels than patients who spontaneously survived ( P = .01). Logistic regression and area under the receiver operating characteristic analysis of CPS1 enzyme-linked immunosorbent assay values improved the accuracy of the ALFSG Prognostic Index, which performed better than the Model for End-Stage Liver Disease, in predicting 21-day transplant-free survival for acetaminophen- but not non-acetaminophen-related ALF. An increase of CPS1 but not alanine transaminase or aspartate transaminase, when comparing day 3 with day 1 levels was found in a higher percentage of acetaminophen transplanted/dead patients ( P < .05). Conclusion Serum CPS1 determination provides a new potential prognostic biomarker to assess patients with acetaminophen-induced ALF.
gastroenterology & hepatology
What problem does this paper attempt to address?